dangers of compounded tirzepatide no longer available Impurity in Some 'Potentially Dangerous,' Eli Lilly Warns Compounded Tirzepatide Compounded GLP-1s: Why doctors worry

Mazdutide is a dual GLP-1/glucagon receptor agonist, offering: - Once-weekly dosing - Strong metabolic impact - Favorable safety profile (mostly GI-related) Why It Matters

The most common adverse effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort

The range of potential uses is varied, from reducing inflammation that may hasten cognitive decline to lowering the risk of major adverse cardiovascular events and treating kidney disease

It is not FDA-approved as a specific compounded drug product the way Mounjaro and Zepbound are, and the FDA has cautioned that compounded versions are not tested for the same batch-to-batch consistency, sterility, or drug-level predictability as the brand products

However, it is advised to reduce alcohol intake while taking this medication

Learn more about Sodium Bicarbonate Sodium Phosphate is is behind-the-scenes formulation helper